Literature DB >> 1974718

The epidermal growth factor receptor and the product of the neu protooncogene are members of a receptor tyrosine phosphorylation cascade.

P A Connelly1, D F Stern.   

Abstract

The protein product of the neu protooncogene, p185, is a tyrosine kinase with a high degree of sequence homology to the epidermal growth factor (EGF) receptor. Although p185 does not bind EGF, EGF stimulates tyrosine phosphorylation of p185. To determine the mechanism of this interaction we have used a vaccinia virus/bacteriophage T7-based transient gene expression system to induce production of normal and kinase-deficient forms of p185 in the absence and presence of EGF receptors. Tyrosine phosphorylation of kinase-deficient p185 was observed, but only in the presence of the EGF receptor. These findings strongly support the hypothesis that p185 is a substrate for the EGF receptor tyrosine kinase in a tyrosine kinase cascade.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1974718      PMCID: PMC54470          DOI: 10.1073/pnas.87.16.6054

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Phosphorylation of middle T by pp60c-src: a switch for binding of phosphatidylinositol 3-kinase and optimal tumorigenesis.

Authors:  D A Talmage; R Freund; A T Young; J Dahl; C J Dawe; T L Benjamin
Journal:  Cell       Date:  1989-10-06       Impact factor: 41.582

Review 2.  Growth factor receptor tyrosine kinases.

Authors:  Y Yarden; A Ullrich
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

3.  Evidence that autophosphorylation of solubilized receptors for epidermal growth factor is mediated by intermolecular cross-phosphorylation.

Authors:  A M Honegger; R M Kris; A Ullrich; J Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

4.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

Authors:  D J Slamon; W Godolphin; L A Jones; J A Holt; S G Wong; D E Keith; W J Levin; S G Stuart; J Udove; A Ullrich
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

5.  Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts.

Authors:  Y Kokai; J N Myers; T Wada; V I Brown; C M LeVea; J G Davis; K Dobashi; M I Greene
Journal:  Cell       Date:  1989-07-28       Impact factor: 41.582

6.  Glycoprotein cytoplasmic domain sequences required for rescue of a vesicular stomatitis virus glycoprotein mutant.

Authors:  M A Whitt; L Chong; J K Rose
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

7.  Autophosphorylation of the PDGF receptor in the kinase insert region regulates interactions with cell proteins.

Authors:  A Kazlauskas; J A Cooper
Journal:  Cell       Date:  1989-09-22       Impact factor: 41.582

8.  Direct evidence that oncogenic tyrosine kinases and cyclic AMP-dependent protein kinase have homologous ATP-binding sites.

Authors:  M P Kamps; S S Taylor; B M Sefton
Journal:  Nature       Date:  1984 Aug 16-22       Impact factor: 49.962

9.  Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody.

Authors:  T Kawamoto; J D Sato; A Le; J Polikoff; G H Sato; J Mendelsohn
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

10.  Kinetic parameters of the protein tyrosine kinase activity of EGF-receptor mutants with individually altered autophosphorylation sites.

Authors:  A Honegger; T J Dull; D Szapary; A Komoriya; R Kris; A Ullrich; J Schlessinger
Journal:  EMBO J       Date:  1988-10       Impact factor: 11.598

View more
  6 in total

1.  Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions.

Authors:  R Pinkas-Kramarski; L Soussan; H Waterman; G Levkowitz; I Alroy; L Klapper; S Lavi; R Seger; B J Ratzkin; M Sela; Y Yarden
Journal:  EMBO J       Date:  1996-05-15       Impact factor: 11.598

Review 2.  The neu-protein and breast cancer.

Authors:  C R De Potter; A M Schelfhout
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

3.  Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: a mechanism of interreceptor kinase activation and transphosphorylation.

Authors:  X Qian; C M LeVea; J K Freeman; W C Dougall; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

4.  Tyrosine kinase activity may be necessary but is not sufficient for c-erbB1-mediated tissue-specific tumorigenicity.

Authors:  D C Connolly; S L Toutenhoofd; N J Maihle
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

5.  Laminin activates the p185HER2 oncoprotein and mediates growth inhibition of breast carcinoma cells.

Authors:  E Tagliabue; E Ardini; R Pellegrini; M Campiglio; R Bufalino; M Jeschke; B Groner; M I Colnaghi; S Ménard
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

6.  Expression and activation of erbB-2 and epidermal growth factor receptor in lung adenocarcinomas.

Authors:  W J Rachwal; P F Bongiorno; M B Orringer; R I Whyte; S P Ethier; D G Beer
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.